GB1458049A - Process for preparing aryl-substituted pyridones - Google Patents

Process for preparing aryl-substituted pyridones

Info

Publication number
GB1458049A
GB1458049A GB4107475A GB4107475A GB1458049A GB 1458049 A GB1458049 A GB 1458049A GB 4107475 A GB4107475 A GB 4107475A GB 4107475 A GB4107475 A GB 4107475A GB 1458049 A GB1458049 A GB 1458049A
Authority
GB
United Kingdom
Prior art keywords
aryl
dec
optionally substituted
substituted pyridones
preparing aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4107475A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AFFILIATED MED RES
Original Assignee
AFFILIATED MED RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00315836A external-priority patent/US3839346A/en
Application filed by AFFILIATED MED RES filed Critical AFFILIATED MED RES
Publication of GB1458049A publication Critical patent/GB1458049A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1458049 Process for aryl-substituted pyridones AFFILIATED MEDICAL RESEARCH Inc 18 Dec 1973 [18 Dec 1972 19 July 1973] 41074/75 Divided out of 1458048 Heading C2C The invention comprises a process for making compounds (I) (where A is an optionally substituted aromatic or hereroaromatic group and R3 to R 6 are H, alkyl or optionally substituted aryl) by reacting (II) or (III) with AX (X is halogen), preferably in the presence of an alkali metal carbonate and finely divided copper. Pharmaceutical preparations having uricosuric and analgesic actions contain (I) as active ingredient.
GB4107475A 1972-12-18 1973-12-18 Process for preparing aryl-substituted pyridones Expired GB1458049A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00315836A US3839346A (en) 1972-12-18 1972-12-18 N-substituted pyridone and general method for preparing pyridones
US38065573A 1973-07-19 1973-07-19

Publications (1)

Publication Number Publication Date
GB1458049A true GB1458049A (en) 1976-12-08

Family

ID=26980095

Family Applications (2)

Application Number Title Priority Date Filing Date
GB4107475A Expired GB1458049A (en) 1972-12-18 1973-12-18 Process for preparing aryl-substituted pyridones
GB5864273A Expired GB1458048A (en) 1972-12-18 1973-12-18 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB5864273A Expired GB1458048A (en) 1972-12-18 1973-12-18 Pharmaceutical composition

Country Status (6)

Country Link
JP (1) JPS4987677A (en)
DE (2) DE2366349C2 (en)
ES (1) ES421598A1 (en)
FR (1) FR2232316B1 (en)
GB (2) GB1458049A (en)
NL (1) NL7317316A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006122154A3 (en) * 2005-05-10 2007-07-26 Intermune Inc Pyridone derivatives for modulating stress-activated protein kinase system
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1049411A (en) * 1972-12-18 1979-02-27 Affiliated Medical Research N-substituted pyridone and general method for preparing pyridones
JPS5350179A (en) * 1976-10-15 1978-05-08 Rikagaku Kenkyusho Novel 2-pyridone compounds and their preparation
JP4542743B2 (en) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 Solution pharmaceutical composition of pyridone derivatives
MX2007009796A (en) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel containing pirfenidone.
DK2670242T3 (en) * 2011-01-31 2022-05-02 Avalyn Pharma Inc Aerosol pirfenidone and pyridone analog compounds and uses thereof
MX2011007675A (en) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Process for manufacturing a pharmaceutical composition in a sustained-release tablet form containing pirfenidone and the application thereof in the regression of chronic renal failure, breast capsular contracture and liver fibrosis in humans.
MX346763B (en) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne.
ITUB20154832A1 (en) * 2015-10-29 2017-04-29 Procos Spa PROCESS FOR SYNTHESIS OF PYRPHENING
CA3108048A1 (en) * 2017-07-31 2019-02-07 Washington University Pirfenidone derivatives for modulation of b lymphocyte activity and organ protection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2947755A (en) * 1959-02-05 1960-08-02 Wallace & Tiernan Inc Substituted 1-m-aminophenyl-2-pyridones
US3655897A (en) * 1971-01-25 1972-04-11 Merck & Co Inc Anti-inflammatory agents

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9527816B2 (en) 2005-05-10 2016-12-27 Intermune, Inc. Method of modulating stress-activated protein kinase system
US10010536B2 (en) 2005-05-10 2018-07-03 Intermune, Inc. Method of modulating stress-activated protein kinase system
EA015252B1 (en) * 2005-05-10 2011-06-30 Интермьюн, Инк. Method of modulating stress-activated protein kinase system
US8741936B2 (en) 2005-05-10 2014-06-03 Intermune, Inc. Method of modulating stress-activated protein kinase system
WO2006122154A3 (en) * 2005-05-10 2007-07-26 Intermune Inc Pyridone derivatives for modulating stress-activated protein kinase system
US7728013B2 (en) 2005-05-10 2010-06-01 Intermune, Inc. Method of modulating stress-activated protein kinase system
US8969347B2 (en) 2008-06-03 2015-03-03 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9290450B2 (en) 2008-06-03 2016-03-22 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
USRE47142E1 (en) 2008-06-03 2018-11-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9675593B2 (en) 2012-10-02 2017-06-13 Intermune, Inc. Anti-fibrotic pyridinones
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones
US10376497B2 (en) 2012-10-02 2019-08-13 Intermune, Inc. Anti-fibrotic pyridinones
US10898474B2 (en) 2012-10-02 2021-01-26 Intermune, Inc. Anti-fibrotic pyridinones
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones
US10544161B2 (en) 2014-04-02 2020-01-28 Intermune, Inc. Anti-fibrotic pyridinones

Also Published As

Publication number Publication date
AU6374673A (en) 1975-06-19
FR2232316A1 (en) 1975-01-03
JPS4987677A (en) 1974-08-22
DE2366349C2 (en) 1986-03-27
FR2232316B1 (en) 1978-03-24
NL7317316A (en) 1974-06-20
ES421598A1 (en) 1977-01-01
DE2362958A1 (en) 1974-06-27
GB1458048A (en) 1976-12-08
DE2362958C2 (en) 1984-06-14

Similar Documents

Publication Publication Date Title
ES446677A1 (en) Propylene oxide reaction products, process for their manufacture and their use
GB1458049A (en) Process for preparing aryl-substituted pyridones
IE832529L (en) ß-CARBOLINES, PROCESS FOR THEIR PRODUCTION AND¹PHARMACEUTICAL PREPARATIONS CONTAINING THEM
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
IE811513L (en) Benzisoselenazolones
EP0104522A3 (en) New pyrazolo(3,4-b)pyridine derivatives and process for producing them
ES8401960A1 (en) Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them.
ES460098A1 (en) Derivatives of penicillanic acid
GB1380225A (en) Biphenylyl- alkanoylaminopyridines and acid addition salts thereof
GB1322512A (en) Substituted azetidinones and process for their manufacture
ES455691A1 (en) N-Benzhydryl-3-methyl-3-(dialkoxy)benzyl-piperazines
ES428949A1 (en) Derivatives of quinoline-8-carboxylic acid having pesticidal action
GB1254414A (en) Novel aminoethanesulfonylamino derivatives and their production
ES8802612A1 (en) Benzisoselenazolonyl derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8104222A1 (en) Alkylcarbapenems, their preparation, use in pharmaceutical compositions and intermediates.
GB1331161A (en) Amino-s-triazolylbenzenesulphonamides
GB1449404A (en) N-arylsulphonyl urea derivatives
ES481271A1 (en) Derivatives of L-cysteine, their use as medicaments and process for their preparation.
GB1448295A (en) Thiosemicarbazones
GB1328169A (en) Benzamide compounds and methods for their production
ES471125A1 (en) 1-Substituted aminoindolines, process for their production and pharmaceutical compositions containing them.
ES8300747A1 (en) Indol acetic derivatives, process for producing the same and pharmaceutical compositions comprising the same.
GB1424143A (en) Process for the resolution of d,1-phenyl propanolamine
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones
ES483027A1 (en) A process for the preparation of aminoacid salts of (-)-cis-1,2- epoxypropylphosphonic acid

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee